Current Approaches in the Management of ITP: From Concept to Consensus | prIME Oncology

Untitled Document

Overview
On behalf of our chairman, Drew Provan, MD, FRCP, FRCPath, we are pleased to invite you to our symposium “Current Approaches in the Management of ITP: From Concept to Consensus” during the 15th Congress of the European Hematology Association in Barcelona, Spain, on 10 June 2010.

Location
Fira de Barcelona Barcelona, Spain Hall G 13.30 – 15.30

Faculty
CHAIR Drew Provan, MD, FRCP, FRCPath Barts and the London NHS Trust The Royal London Hospital London, United Kingdom FACULTY James B. Bussel, MD Weill Medical College of Cornell University New York, New York, United States Miguel Angel Sanz, MD, PhD Hospital University La Fe Valencia, Spain Roberto Stasi, MD, PhD St Georges Healthcare NHS Trust London, United Kingdom

Agenda

13.30		Welcome & demographic questions Drew Provan, MD, FRCP, FRCPath
13.45		Defining the issues and opportunities in the management of ITP Roberto Stasi, MD, PhD
14.05		Responding to the challenge of platelet production: Thrombopoietin receptor agonist therapy James Bussel, MD
14.35		ITP: Building consensus for clinical practice Drew Provan, MD, FRCP, FRCPath
14.55		Patient management: What to do and when to do it All faculty: James Bussel, MD; Drew Provan, MD, FRCP, FRCPath; Miguel Sanz, MD, PhD; Roberto Stasi, MD, PhD
15.30		Concluding remarks Drew Provan, MD, FRCP, FRCPath

Support
Support for this activity has been provided by GlaxoSmithKline